Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-06

Clinical Trial Update: A Study Evaluating Soticlestat in Participants With Dravet Syndrome or Lennox-Gastaut Syndrome Who Have Been Exposed to Fenfluramine [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating soticlestat in Dravet syndrome or Lennox-Gastaut syndrome patients with prior fenfluramine exposure was terminated; results have been p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Soticlestat (soticlestat)

Snippet

Sponsor: Takeda | Conditions: Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS) | Phase 3 | Status: TERMINATED | Results posted: 2025-03-06